| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,871 |
32,234 |
$3.80M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,405 |
8,039 |
$949K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
577 |
547 |
$64K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
452 |
419 |
$45K |
| 99051 |
|
1,701 |
1,499 |
$27K |
| 99050 |
|
1,474 |
1,324 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
114 |
110 |
$15K |
| 99201 |
|
130 |
118 |
$13K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
42 |
41 |
$6K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
438 |
412 |
$5K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
249 |
245 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
726 |
597 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,842 |
1,534 |
$251.98 |
| 0002A |
|
84 |
83 |
$143.48 |
| 0031A |
|
20 |
20 |
$133.65 |
| 0012A |
|
19 |
19 |
$107.61 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,320 |
1,861 |
$74.00 |
| 92551 |
|
348 |
340 |
$58.61 |
| 99173 |
|
347 |
339 |
$52.01 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,988 |
1,642 |
$37.00 |
| 87428 |
|
35 |
35 |
$28.27 |
| 0011A |
|
21 |
21 |
$18.10 |
| 0521F |
|
225 |
160 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
71 |
46 |
$0.00 |
| 81025 |
|
29 |
25 |
$0.00 |
| 1159F |
|
523 |
398 |
$0.00 |
| 81003 |
|
330 |
279 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
106 |
92 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
102 |
99 |
$0.00 |
| 91300 |
|
149 |
140 |
$0.00 |
| 90715 |
|
36 |
33 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
60 |
41 |
$0.00 |
| 1160F |
|
51 |
51 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
28 |
25 |
$0.00 |
| 3351F |
|
1,649 |
1,339 |
$0.00 |
| 3008F |
|
867 |
649 |
$0.00 |
| 0001A |
|
85 |
85 |
$0.00 |
| 1030F |
|
1,273 |
986 |
$0.00 |
| 1125F |
|
275 |
200 |
$0.00 |
| 87280 |
|
295 |
240 |
$0.00 |
| 1036F |
|
280 |
190 |
$0.00 |
| 36416 |
|
43 |
39 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
168 |
126 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
105 |
92 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
34 |
17 |
$0.00 |
| 90686 |
|
17 |
15 |
$0.00 |
| 91303 |
|
16 |
16 |
$0.00 |
| 1126F |
|
31 |
13 |
$0.00 |
| 90651 |
|
18 |
15 |
$0.00 |
| 3074F |
|
29 |
24 |
$0.00 |
| 91301 |
|
50 |
50 |
$0.00 |
| 3079F |
|
14 |
14 |
$0.00 |